Helicobacter Pylori Infection and Lung Cancer: New Insights and Future Challenges
- PMID: 30201063
- PMCID: PMC6137001
- DOI: 10.3779/j.issn.1009-3419.2018.09.03
Helicobacter Pylori Infection and Lung Cancer: New Insights and Future Challenges
Abstract
Helicobacter pylori (H. pylori) is the causative agent of chronic gastritis and peptic ulcer diseases and is an important risk factor for the development functional dyspepsia, peptic ulceration, gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma. H. pylori has very high rates of infection in human populations, and it is estimated that over 50% of the world population is infected. Recently, certain extra-gastric manifestations, linked to H. pylori infection, have been widely investigated. Noteworthy, a growing body of evidences supports an association between H. pylori infection with lung cancer. The present review intend to highlight not only the most recent evidences supporting this association, but also some missed points, which must be considered to validate this emerging association.
Keywords: Air pollution; Chronic inflammation; Damage-associated molecular patterns; Helicobacter pylori; Lung neoplasms; Pathogen-associated molecular patterns.
Similar articles
-
Is Helicobacter pylori good or bad?Eur J Clin Microbiol Infect Dis. 2013 Mar;32(3):301-4. doi: 10.1007/s10096-012-1773-9. Epub 2012 Nov 7. Eur J Clin Microbiol Infect Dis. 2013. PMID: 23132690 Review.
-
Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.CMAJ. 1994 Jan 15;150(2):177-85. CMAJ. 1994. PMID: 8287340 Free PMC article. Review.
-
How host regulation of Helicobacter pylori-induced gastritis protects against peptic ulcer disease and gastric cancer.Am J Physiol Gastrointest Liver Physiol. 2016 Sep 1;311(3):G514-20. doi: 10.1152/ajpgi.00146.2016. Epub 2016 Jul 28. Am J Physiol Gastrointest Liver Physiol. 2016. PMID: 27469367 Review.
-
Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000.Curr Pharm Des. 2000 Oct;6(15):1503-14. doi: 10.2174/1381612003399112. Curr Pharm Des. 2000. PMID: 10974147 Review.
-
Association of Helicobacter pylori with gastroduodenal diseases.Jpn J Infect Dis. 1999 Oct;52(5):183-97. Jpn J Infect Dis. 1999. PMID: 10680084 Review.
Cited by
-
The role of oral microbiota in cancer.Front Microbiol. 2023 Oct 24;14:1253025. doi: 10.3389/fmicb.2023.1253025. eCollection 2023. Front Microbiol. 2023. PMID: 37954233 Free PMC article. Review.
-
The TLR4/ERK/PD‑L1 axis may contribute to NSCLC initiation.Int J Oncol. 2020 Aug;57(2):456-465. doi: 10.3892/ijo.2020.5068. Epub 2020 May 19. Int J Oncol. 2020. PMID: 32468028 Free PMC article.
-
The Lung Microbiome in COPD and Lung Cancer: Exploring the Potential of Metal-Based Drugs.Int J Mol Sci. 2023 Aug 1;24(15):12296. doi: 10.3390/ijms241512296. Int J Mol Sci. 2023. PMID: 37569672 Free PMC article. Review.
-
Association between Helicobacter pylori and its eradication and the development of cancer.BMJ Open Gastroenterol. 2024 Aug 24;11(1):e001377. doi: 10.1136/bmjgast-2024-001377. BMJ Open Gastroenterol. 2024. PMID: 39181567 Free PMC article.
-
Role of Helicobacter pylori infection in the manifestation of old age-related diseases.Mol Genet Genomic Med. 2020 Apr;8(4):e1157. doi: 10.1002/mgg3.1157. Epub 2020 Feb 17. Mol Genet Genomic Med. 2020. PMID: 32067423 Free PMC article. Review.
References
-
- Schistosomes, liver flukes, Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. http://europepmc.org/abstract/MED/7715068. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical